| Identification | Back Directory | [Name]
REBAMIPIDE | [CAS]
111911-87-6 | [Synonyms]
REBAPIMIDE
REBAMIPIDE, 99+%
REBAMIPIDE USP/EP/BP
RebaMipide(OPC-12759)
alpha-((4-chlorobenzoyl)amino)-1,2-dihydro-2-oxo-4-quinolinepropanicaci(+
Alpha-[(4-Chlorobenzoyl)Amino]-1,2-Dihydro-2-Oxo-4-Quinolinepropanoicacid
(+-)-alpha-((4-chlorobenzoyl)amino)-1,2-dihydro-2-oxo-4-quinolinepropanicaci
2-[[(4-chlorophenyl)-oxomethyl]amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid | [EINECS(EC#)]
1806241-263-5 | [Molecular Formula]
C19H15ClN2O4 | [MDL Number]
MFCD00866895 | [MOL File]
111911-87-6.mol | [Molecular Weight]
370.79 |
| Hazard Information | Back Directory | [Description]
Rebamipide is a quinolinone derivative introduced as a novel antiulcer agent. It acts
as a local gastric mucosa prostaglandin inducer and is reported to be effective in both the healing and prevention of recurrence of gastric ulcer. | [Originator]
Otsuka (Japan) | [Definition]
ChEBI: 2-[[(4-chlorophenyl)-oxomethyl]amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid is a secondary carboxamide. | [Brand name]
Mucosta |
|
|